Profund Advisors LLC Cuts Position in CVS Health Corporation $CVS

Profund Advisors LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 6.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,155 shares of the pharmacy operator’s stock after selling 1,093 shares during the period. Profund Advisors LLC’s holdings in CVS Health were worth $1,114,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in CVS. Avion Wealth boosted its holdings in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the 2nd quarter valued at approximately $30,000. Bell Investment Advisors Inc boosted its stake in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC grew its holdings in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the period. Finally, ORG Partners LLC increased its stake in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS opened at $79.73 on Wednesday. The company has a 50-day simple moving average of $77.36 and a 200-day simple moving average of $69.67. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62. The company has a market cap of $101.22 billion, a PE ratio of 209.83, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s payout ratio is currently 700.00%.

Analyst Ratings Changes

A number of analysts have commented on CVS shares. The Goldman Sachs Group assumed coverage on CVS Health in a research report on Tuesday, October 14th. They set a “buy” rating and a $91.00 target price on the stock. Sanford C. Bernstein lifted their price target on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Jefferies Financial Group lifted their target price on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Finally, Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $89.45.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.22% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.